Scavenger Receptor Class A1 Mediates Uptake of Morpholino Antisense Oligonucleotide into Dystrophic Skeletal Muscle-Reference-Cited by-同舟云学术

Scavenger Receptor Class A1 Mediates Uptake of Morpholino Antisense Oligonucleotide into Dystrophic Skeletal Muscle

Published:2019-03 Issue: Volume:14 Page:520-535
ISSN:2162-2531
Container-title:Molecular Therapy - Nucleic Acids
language:en
Short-container-title:Molecular Therapy - Nucleic Acids

Author:

Miyatake Shouta,Mizobe Yoshitaka,Tsoumpra Maria K.,Lim Kenji Rowel Q.,Hara Yuko,Shabanpoor Fazel,Yokota Toshifumi,Takeda Shin’ichi,Aoki Yoshitsugu

Funder

Japan Society for the Promotion of Science Grant-in-Aid for Scientific Research

Grants-in-Aid for Research on Nervous and Mental Disorders

Japan Agency for Medical Research and Development

Publisher

Elsevier BV

Subject

Drug Discovery,Molecular Medicine

Reference60 articles.

1. Recent advances in innovative therapeutic approaches for Duchenne muscular dystrophy: from discovery to clinical trials;Shimizu-Motohashi;Am. J. Transl. Res.,2016

2. Bodywide skipping of exons 45-55 in dystrophic mdx52 mice by systemic antisense delivery;Aoki;Proc. Natl. Acad. Sci. USA,2012

3. RNA therapeutics: beyond RNA interference and antisense oligonucleotides;Kole;Nat. Rev. Drug Discov.,2012

4. Neutrally charged phosphorodiamidate morpholino antisense oligomers: uptake, efficacy and pharmacokinetics;Arora;Curr. Pharm. Biotechnol.,2004

5. Systemic delivery of antisense oligoribonucleotide restores dystrophin expression in body-wide skeletal muscles;Lu;Proc. Natl. Acad. Sci. USA,2005

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Usefulness of Determining Plasma and Tissue Concentrations of Phosphorodiamidate Morpholino Oligonucleotides to Estimate Their Efficacy in Duchenne Muscular Dystrophy Patients;Drug Metabolism and Disposition;2024-07-11

2. Comparing Cell Penetration of Biotherapeutics across Human Cell Lines;ACS Chemical Biology;2024-06-05

3. Comparing cell penetration of biotherapeutics across human cell lines;2024-03-31

4. Development of nucleic acid medicines based on chemical technology;Advanced Drug Delivery Reviews;2023-08

5. Enhancing the Effectiveness of Oligonucleotide Therapeutics Using Cell-Penetrating Peptide Conjugation, Chemical Modification, and Carrier-Based Delivery Strategies;Pharmaceutics;2023-04-03